The International Biosimilars Summit 2018 is dedicated to Trends of biosimilars, commercial strategy, effective planning and strategies for biosimilars future development.
Topics
- Emerging investment trends and opportunities
- Biosimilar adoption and challenges facing market uptake
- The European biosimilar landscape, what does the future hold
- Emerging business models and their impact on biosimilar development
- Forecasting biosimilar product portfolios and effectively planning and aligning business strategies for future changes
- Commercial strategy to increase market uptake
- The Experience Exchange: Developing and Introducing Biosimilars to New Markets
- Facilitating the acceptance and increasing the uptake of biosimilars
- Biosimilars In Emerging Markets – Regulatory and Commercial Considerations
- Pharmacovigilance issues related to biosimilars
Who should Attend
Senior attendees with responsibilities in:
- New Product Development
- Biosimilar Companies
- Pharmaceutical and Biotech Companies
- Biologics/Biotechnology/Biogenerics
- Pharmacy Benefit Managers
- Quality Affairs/ Quality Control
- Healthcare Providers
- Payers & Health Insurers
- Investors & Financiers
- Government/Policy Makers
- Regulatory Compliance
- Legal Affairs and Law Firms
- Preclinical and Clinical Development
- Intellectual property
- From Industries Including
- Business Development
- Pharmaceutical
- Biosimilar,
- Biotechnology
- Biopharmaceutical
- Solution provider companies
- Diagnostics
- CDx entities
- Research Institutes
- Payers & Health Insurers
- Healthcare Providers
- Investors & Financiers
- Government institutions
- Trade Organizations and others
- Law Firms
